Abstract
The plasma adenosine 3′, 5′ — cyclic monophosphate (cyclic AMP) response to 50 μg of intravenous glucagon was examined in 14 normal euthyroid subjects, 15 patients with thyrotoxicosis and 5 patients with myxedema. The cyclic AMP response to 50 μg of intravenous glucagon was significantly higher in the hyperthyroid group than in the euthyroid or hypothyroid group. However, the areas of overlap between all three groups were large and there was little relationship between the plasma cyclic AMP response to glucagon and the biochemical assessment of thyroid function. Serial studies of the response to 50 μg glucagon were carried out in four patients receiving treatment for thyrotoxicosis. Again, there was no consistent relationship between the plasma cyclic AMP responsiveness to glucagon and the free thyroxine index. It is concluded that although the plasma cyclic AMP response to glucagon is increased in thyrotoxicosis and decreased in myxedema, the variability of this response in thyroid disease precludes its use as a tissue index of thyroid hormone responsiveness.
Similar content being viewed by others
References
Broadus A.D., Kaminsky N.I., Northcutt R.C., Hardman J.G., Sutherland E.W., Liddle G.W. Effects of glucagon on adenosine 3, 5′-monophosphate and guanosine 3′, 5′-monophosphate in human plasma and urine. J. Clin. Invest. 49: 2237, 1970.
Elkeles R.S., Lazarus J.H., Siddle K., Campbell A.K. Plasma adenosine 3′, 5′-cyclic monophosphate response to glucagon in thyroid disease. Clin. Sci. Mol. Med. 48: 27, 1975.
Lazarus J.H. Shetty K.J., Siddle K. The value of the glucagon induced rise in plasma adenosine 3′, 5′-cyclic monophosphate in assessing thyroid status. In: Robbins J., Braveman L.E. (Eds.), Thyroid Research. Excerpta Medica, Amsterdam, 1976, p. 609.
Madsen S.N. Thyroid function and plasma cyclic AMP response to intravenous glucagon. Acta Endocrinol. (Kbh.) 85: 760, 1977.
Hendy Q.N., Tomlinson S., O’Riordan J.L.H. Impaired responsiveness to the effect of glucagon on plasma adenosine 3′, 5′-cyclic monophosphate in normal man. Acta Endocrinol. (Kbh.) 85: 760, 1977.
Guttler R.B., Shaw J.W., Otis C., Nicoloff J.T. Epinephrine-induced alterations in urinary cyclic AMP in hyper and hypothyroidism. J. Clin. Endocrinol. Metab. 41: 707, 1975.
Ashby J.P., MacPherson J.N., Strong J.A. The relationship between thyroid function and the renal response to parathyroid hormone. Clin. Endocrinol. (Oxf.) 7: 167, 1977.
Madsen S.N., Sonne O. Increase of glucagon receptors in hyperthyroidism. Nature 262: 793, 1976.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mac Neil, S., Hendy, G.N., Amirrasooli, H. et al. Investigation of the usefulness of the plasma adenosine 3′, 5′ — cyclic monophosphate response to glucagon in thyroid disease. J Endocrinol Invest 3, 401–404 (1980). https://doi.org/10.1007/BF03349378
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03349378